Literature DB >> 10978180

A catalytically deficient active site variant of PvuII endonuclease binds Mg(II) ions.

C M Dupureur1, L H Conlan.   

Abstract

In efforts to understand the mechanisms of many nucleic acid enzymes, the first site-directed mutations are made at conserved acidic active residues. Almost without exception, the low or null activities of the resulting variants are attributed to the importance of the acidic residue(s) to the ligation of required metal ions. Using (25)Mg NMR spectroscopy as a direct probe of metal ion binding and the homodimeric PvuII restriction endonuclease as a model system, this interpretation is examined and clarified. Our results indicate that Mg(II) binds wild-type PvuII endonuclease in the absence of DNA with a K(d,app) of 1.9 mM. Hill analysis yields an n(H) coefficient of 1.4, a value consistent with the binding of more than one Mg(II) ion per monomer active site. Variable pH studies indicate that two ionizable groups are responsible for Mg(II) binding by wild-type PvuII endonuclease near physiological pH. The pK(a,app) for these ionizations is 6.7, a value which is unusual for acidic residues but consistent with data obtained for critical groups in MunI endonuclease and a number of other hydrolases. To assign residues critical to ligating Mg(II), binding measurements were performed on the low activity catalytic site mutants E68A and D58A. As expected, E68A binds Mg(II) ions very weakly (K(d,app) approximately 40 mM), implicating Glu68 as critical to Mg(II) binding. Interestingly, while D58A has only residual specific activity, it retains an affinity for Mg(II) with a K(d,app) of 3.6 mM and exhibits a Hill coefficient of 0.7. Moreover, in this variant, multiple ionizable groups with pK(a,app) of 7.2 are involved in Mg(II) binding, suggesting a shuffling of Mg(II) ligands in the active site. These data indicate that Asp58 is important for the critical positioning of metal ion(s) required for catalysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978180     DOI: 10.1021/bi000337d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Nucleophile activation in PD...(D/E)xK metallonucleases: an experimental and computational pK(a) study.

Authors:  Fuqian Xie; James M Briggs; Cynthia M Dupureur
Journal:  J Inorg Biochem       Date:  2010-03-06       Impact factor: 4.155

2.  Metal ion and DNA binding by single-chain PvuII endonuclease: lessons from the linker.

Authors:  Grigorios A Papadakos; Cynthia M Dupureur
Journal:  J Biol Inorg Chem       Date:  2011-07-03       Impact factor: 3.358

Review 3.  Structure and function of type II restriction endonucleases.

Authors:  A Pingoud; A Jeltsch
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

4.  ESR spectroscopy identifies inhibitory Cu2+ sites in a DNA-modifying enzyme to reveal determinants of catalytic specificity.

Authors:  Zhongyu Yang; Michael R Kurpiewski; Ming Ji; Jacque E Townsend; Preeti Mehta; Linda Jen-Jacobson; Sunil Saxena
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

5.  Characterizing metalloendonuclease mixed metal complexes by global kinetic analysis.

Authors:  Charulata B Prasannan; Fuqian Xie; Cynthia M Dupureur
Journal:  J Biol Inorg Chem       Date:  2010-01-19       Impact factor: 3.358

6.  One- and two-metal ion catalysis: global single-turnover kinetic analysis of the PvuII endonuclease mechanism.

Authors:  Fuqian Xie; Shabir H Qureshi; Grigorios A Papadakos; Cynthia M Dupureur
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

7.  Kinetic analysis of product release and metal ions in a metallonuclease.

Authors:  Fuqian Xie; Cynthia M Dupureur
Journal:  Arch Biochem Biophys       Date:  2009-01-10       Impact factor: 4.013

8.  Uncoupling metallonuclease metal ion binding sites via nudge mutagenesis.

Authors:  Grigorios A Papadakos; Horacio Nastri; Paul Riggs; Cynthia M Dupureur
Journal:  J Biol Inorg Chem       Date:  2007-02-17       Impact factor: 3.862

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.